Semax
Synthetic nootropic peptide used for cognitive support and neurorecovery, primarily studied in Russia for cerebrovascular disorders.
Semax
Synthetic nootropic peptide used for cognitive support and neurorecovery, primarily studied in Russia for cerebrovascular disorders.
Niche peptide with limited human evidence outside Russia; skip unless you are experimenting under medical supervision.
Semax is a synthetic heptapeptide developed in Russia as a nootropic and neuroprotective nasal spray. Derived from an adrenocorticotropic hormone fragment, it is thought to modulate brain-derived neurotrophic factor and melanocortin receptors. Russian clinical use focuses on cognitive impairment, cerebrovascular insufficiency, and recovery after stroke or brain injury. Outside Russia, high-quality randomized trials are scarce, and it lacks Western regulatory approval. It may interest biohackers and those with neurological concerns, but evidence for enhancement in healthy adults remains prelimi
Proven Benefits
Protocol
Onset Time
Who Should Consider
How It Works
Semax appears to modulate brain-derived neurotrophic factor and its TrkB receptor, supporting neuronal survival and synaptic plasticity. It also interacts with melanocortin receptors and may influence cerebral blood flow and local immune responses in the central nervous system, though most mechanistic data derives from animal models.